Patent Applications for TARCEVA

US Patent Applications for TARCEVA

US Patent Application	Patent No.	Title	Patent Filing Date	Patent Application Status	Status Updated
		Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist	2002-03-04	Abandoned -- Failure to Respond to an Office Action	2007-10-01
		BENZOQUINONE ANSAMYCINS	2002-08-05	Patented Case	2005-03-09
		N- (3-ETHYNYLPHENYL) -6, 7-BIS (2-METHOXYETHOXY) -4-QUINAZOLINAMINE MESYLATE ANHYDRATE AND MONOHYDRATE	2003-11-17	Patented Case	2009-04-01
		Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy	2003-11-14	Abandoned -- Failure to Respond to an Office Action	2008-01-07
		NOVEL [6,7-BIS(2-METHOXY-ETHOXY)-QUINAZOLIN-4-YL]-(3-ETHYNYL-PHENYL)AMINE HYDROCHLORIDE POLYMORPH	2004-02-03	Patented Case	2006-11-22
		TREATING ABNORMAL CELL GROWTH WITH A STABLE POLYMORPH OF N-(3-ETHYNYLPHENYL)-6,7-BIS (2-METHOXYETHOXY)-4-QUINAZOLINAMINE HYDROCHLORIDE	2004-11-18	Patented Case	2006-07-19

WIPO Patent Applications for TARCEVA

WIPO Patent Application	Title	Patent Filing Date

Japanese Patent Applications for TARCEVA

JP Patent Application	Title	Patent Filing Date